Other examples of the ways our PBTK modeling & simulation scientists can assist with your research include:
- in silico screening of compound libraries based on PK endpoints (F%, Cmax, AUC)
- extrapolation of in vitro metabolism and transport data to in vivo values (IVIVE) and predicting exposures in animals and humans
- population toxicokinetic and toxicodynamic predictions for different age groups
- conduct virtual bioequivalence (BE) trials to optimize study design
- prediction of tissue concentrations
All major regulatory agencies around the world, including the U.S., Canada, Europe, China, and Japan have licenses to GastroPlus, with reviewers in all divisions trained on the program. Our reputation and credibility at regulatory agencies has led our clients to deploy GastroPlus as an integral component of compound evaluation prior to regulatory interactions and submissions.